Early outcome of transcatheter aortic-valve implantation in high risk patients: The Auckland experience from 2011 to 2014
Up to one third of patients may be denied surgical aortic valve replacement (AVR) because of co-morbid conditions. Transcatheter aortic-valve implantation (TAVI) is an alternative to aortic valve replacement in high risk patients with symptomatic severe aortic stenosis.
S. Wu, J. Stewart, M. Webster, J. White
Auckland City Hospital Cardiology Department, Auckland
Heart, Lung and Circulation – Volume 23, Supplement 1, e1-e48
Abstract & full-text available.
Resource Library Item
This resource is available for registered members of CSANZ.
Click the button below to log in to HeartOne and access this resource. Please note that CPD credit is NOT automatically assigned for accessing resources directly.